Tissue resources for clinical use and marker studies in melanoma
- PMID: 24259006
- PMCID: PMC4780253
- DOI: 10.1007/978-1-62703-727-3_37
Tissue resources for clinical use and marker studies in melanoma
Abstract
The adequate procurement and preservation of high-quality tissue specimens from patients with melanoma is a critical clinical issue as patients' tumor samples are now used not only for pathological diagnosis but are also necessary to determine the molecular signature of the tumor to stratify patients who may benefit from targeted melanoma therapy. Tissue resources available for physicians and investigators include formalin-fixed paraffin-embedded (FFPE) tissue and frozen tissue, either preserved in optimal cutting temperature (OCT) media or snap frozen. Properly preserved tissue may be used to evaluate melanoma biomarkers by immunohistochemistry (IHC) with tissue microarray (TMA) technology, to perform genetic and genomic analyses, and for other types of translational research in melanoma.
Figures
References
-
- Wilson M, Zhao F, Letrero R, et al. Somatic mutation status of melanomas and effect on clinical outcome in patients on ECOG 2603. Society for Melanoma Research 2012 Congress; Hollywood, CA. 2012.
-
- Becker D, Mihm MC, Hewitt SM, et al. Markers and tissue resources for melanoma: meeting report. Cancer Res. 2006;66:10652–10657. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
